| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |